Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
Go back to Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)| Pfizer Inc. (NYSE: PFE) | Delayed: 28.46 +0.50 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.96 | 52 Week High | $37.39 | |||
| Open | $27.85 | 52 Week Low | $28.25 | |||
| Day High | $28.70 | P/E | 17.25 | |||
| Day Low | $27.64 | EPS | $1.65 | |||
| Volume | 44,148,300 | |||||
